TD Cowen analyst Charles Rhyee lowered the firm’s price target on Walgreens Boots Alliance to $22 from $35 and keeps a Buy rating on the shares. The price target update reflects Q3 results, revised FY24 guidance, and management’s FY25 commentary. While a turnaround will be challenging, the firm is encouraged by the actions management is taking, including accelerated store closures and reconfiguring the retail experience, and awaits further financial details in October, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Boots chief quitting as Walgreens’ sale plan stalls, Reuters reports
- Walgreens Boots Alliance price target lowered to $13 from $20 at Truist
- Walgreens Boots Alliance price target lowered to $10 from $17 at Evercore ISI
- Walgreens Boots Alliance price target lowered to $11 from $22 at BofA
- Walgreens Boots Alliance price target lowered to $9 from $13 at Morgan Stanley